RE:RE:RE:RE:RE:Ceapro will go bankrupt in the end?for the Q1 result, the CEO attributed to spin off of JNJ, and never mentioned other reasons.
for the Q2 result, CEO changed his words, said it also due to JNJ over ordering in 2021- 2022. If this was the case, why he hided this important information in 2021-2022 annual reports. The management just told shareholders the 2021- 2022 earnings were great, so they should get big bonus and options. Can shareholders should trust this kind of management team?